ロード中...
Combination therapy in cholesterol reduction: focus on ezetimibe and statins
Although widely used in lipid lowering therapy, HMG CoA reductase inhibitors (even when administered at high doses) are frequently insufficient to achieve guideline-recommended LDL-C goals for many patients with hypercholesterolemia in everyday clinical practice. Many patients do not achieve LDL-C g...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2496970/ https://ncbi.nlm.nih.gov/pubmed/18561502 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|